MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) - A Qualitative Study of Patient-voiced Research Priorities Across Rare Myositis Diseases

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research priorities. The PRISMS study is a global investigation that collects patient perspectives through (mostly online) methods of open-ended questions, community forums and survey to identify the most pressing research concerns as identified by patients. Findings will be analyzed to create a patient-voiced set of research priorities that can guide the direction of research and help inform funding decisions across myositis diseases. Potential participants can express interest via https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/

Eligibility
Participation Requirements
Sex: All
Minimum Age: 7
Healthy Volunteers: f
View:

• Ability to provide informed consent

• Have a clinician diagnosis of an idiopathic inflammatory myopathy or be a care partner or parent of a person living with an idiopathic inflammatory myopathy.

• Participants who may have signed up through the MIHRA Patient Contact Registry https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/

Locations
United States
Louisiana
MIHRA Foundation - This is a GLOBAL STUDY
RECRUITING
New Orleans
Contact Information
Primary
Lesley Ann Saketkoo, MD/MPH
info@MiHRAfoundation.org
504 822 6653
Backup
Barbara Shafranski
info@MIHRAfoundation.org
504 822 6653
Time Frame
Start Date: 2025-06-25
Estimated Completion Date: 2030-12
Participants
Target number of participants: 700
Treatments
Individuals living with a myositis disease
Adults and children with a clinician diagnosis of an inflammatory myopathy (and optionally caregivers/partners) will express their priorities and insights regarding regarding research priorities across myositis diseases.
Related Therapeutic Areas
Sponsors
Collaborators: The Swedish Myositis Association, Myositis UK, The Dutch Myositis Association, PReS - Paediatric Rheumatology European Society, CARRA - Childhood Arthritis & Rheumatology Research Alliance, The German Myositis Association, MIHRA Patient Advisory, CureJM, Myositis Australia, The Myositis Association
Leads: Myositis International Health & Research Collaborative Alliance Foundation

This content was sourced from clinicaltrials.gov